Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Gross Profit: 2013-2024

Historic Gross Profit for vTv Therapeutics (VTVT) over the last 12 years, with Dec 2024 value amounting to $1.0 million.

  • vTv Therapeutics' Gross Profit was N/A to -$5,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2024, which is 1068.97% up from last year.
  • According to the latest figures from FY2024, vTv Therapeutics' Gross Profit is $1.0 million, which was up 1,068.97% from $87,000 recorded in FY2023.
  • vTv Therapeutics' Gross Profit's 5-year high stood at $6.4 million during FY2020, with a 5-year trough of $87,000 in FY2023.
  • For the 3-year period, vTv Therapeutics' Gross Profit averaged around $1.0 million, with its median value being $1.0 million (2024).
  • In the last 5 years, vTv Therapeutics' Gross Profit plummeted by 95.69% in 2023 and then skyrocketed by 1,068.97% in 2024.
  • Over the past 5 years, vTv Therapeutics' Gross Profit (Yearly) stood at $6.4 million in 2020, then tumbled by 37.56% to $4.0 million in 2021, then slumped by 49.61% to $2.0 million in 2022, then plummeted by 95.69% to $87,000 in 2023, then skyrocketed by 1,068.97% to $1.0 million in 2024.